MED18 anticorps (AA 31-130) (Cy7)
Aperçu rapide pour MED18 anticorps (AA 31-130) (Cy7) (ABIN6986156)
Antigène
Voir toutes MED18 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 31-130
-
Réactivité croisée
- Humain, Souris, Rat
-
Homologie
- Dog,Cow,Sheep,Pig,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human MED18
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- MED18 (Mediator Complex Subunit 18 (MED18))
-
Autre désignation
- MED18
-
Sujet
-
Synonyms: FLJ20045, hMED 18, hMED18, Human Mediator of RNA Polymerase II Transcription, MED 18, med18, MED18_HUMAN, Mediator complex subunit 18, Mediator of RNA polymerase II transcription subunit 18, Mediator of RNA polymerase II transcription subunit 18 homolog, OTTHUMP00000003645, p28b, TRAP/mediator complex subunit p28b.
Background: MED18 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008]
-
ID gène
- 54797
-
UniProt
- Q9BUE0
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-